Silexon (燧坤智能)
Nanjing, China
Silexon is founded and managed by interdisciplinary experts equipped with both biopharmaceutical and computer science/machine learning domain knowledge. Silexon aims to create an open AI platform for strategic collaboration in order to facilitate data-driven life science research and empower drug R&D process, and ultimately provide patients with greater access to innovative drugs for unmet medical needs. Since incorporation, Silexon has identified several lead compounds with collaborators and through in house programs for various targets such as kinase, GPCR and others. Silexon has also been in close discussions with several multinational pharmaceutical companies regarding potential collaboration on drug repurposing, drug discovery/virtual HTS and protein yield increase.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- www.silexon.tech
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Silexon (燧坤智能)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now